Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Endocrine System01:29

The Endocrine System

796
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
796
An Overview of the Endocrine System01:10

An Overview of the Endocrine System

10.0K
The endocrine system, a complex network of glands, orchestrates physiological balance within the body through the production and secretion of hormones. These hormones are chemical messengers in intercellular communication, acting as conduits between the secretory cells and distant target sites. They traverse the circulatory system by being released into the extracellular fluid, and their impact is specific to cells possessing receptors for a particular hormone.
The endocrine system collaborates...
10.0K
Endocrine Signaling01:45

Endocrine Signaling

65.3K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
65.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

4.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.5K
Structures of the Endocrine System00:59

Structures of the Endocrine System

8.7K
The intricate framework of the endocrine system encompasses a diverse array of glands, with their target tissues and organs strategically distributed throughout the body. Central to this network are the endocrine glands, specialized structures that lack ducts and release hormones directly into the interstitial fluid. Notably, the hypothalamus, a vital neuroendocrine organ situated in the brain, governs neural functions and serves as a potent source of hormonal regulation. Near the hypothalamus...
8.7K
What is the Endocrine System?00:46

What is the Endocrine System?

417.3K
The endocrine system sends hormones—chemical signals—through the bloodstream to target cells—the cells the hormones selectively affect. These signals are produced in endocrine cells, secreted into the extracellular fluid, and then diffuse into the blood. Eventually, they diffuse out of the blood and bind to target cells which have specialized receptors to recognize the hormones.
417.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma oxytocin, early predictor of transient postoperative arginine vasopressin deficiency.

The Journal of clinical endocrinology and metabolism·2026
Same author

Biochemical and clinical remission after adrenalectomy in patients with primary aldosteronism: a retrospective two-center study.

Gland surgery·2026
Same author

Autofluorescence enhances intraoperative detection of parathyroid glands: a single-center comparative study.

Frontiers in endocrinology·2026
Same author

Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

European journal of endocrinology·2026
Same author

Endocrine care of transgender and gender-diverse adults: Swiss recommendations.

Swiss medical weekly·2026
Same author

Lesional dosimetry in <sup>131</sup>I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026

Related Experiment Video

Updated: Oct 6, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

115

[What's new in endocrinology].

Maria Mavromati1, Sophie Leboulleux1

  • 1Service d'endocrinologie, diabétologie, nutrition et éducation thérapeutique, Hôpitaux universitaires de Genève, 1211 Genève 14.

Revue Medicale Suisse
|January 20, 2022
PubMed
Summary

New 2021 guidelines simplify differentiated thyroid cancer treatment and personalize acromegaly management. Graves

Area of Science:

  • Endocrinology
  • Oncology
  • Ophthalmology

Background:

  • Graves' orbitopathy is a significant cause of morbidity associated with Graves' disease.
  • Differentiated thyroid cancer management has evolved, particularly for low-risk cases.
  • Acromegaly treatment requires a tailored approach considering prognostic factors and complications.

Purpose of the Study:

  • To present new recommendations for managing Graves' orbitopathy.
  • To outline a simplified treatment strategy for low-risk differentiated thyroid cancer.
  • To describe a personalized management approach for acromegaly.

Main Methods:

  • Review of 2021 published recommendations.
  • Analysis of treatment strategies for differentiated thyroid cancer.

More Related Videos

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
06:35

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Published on: April 5, 2024

1.2K
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

94.9K

Related Experiment Videos

Last Updated: Oct 6, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

115
Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
06:35

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Published on: April 5, 2024

1.2K
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

94.9K
  • Evaluation of personalized approaches and complication management in acromegaly.

    • Main Results:

    • New recommendations for Graves' orbitopathy management are available.
    • Treatment for low-risk differentiated thyroid cancer is simplified, involving less surgery and lower-dose radioiodine.
    • Acromegaly management is personalized, utilizing prognostic factors and emphasizing complication treatment.

    Conclusions:

    • Updated guidelines offer improved management for Graves' orbitopathy.
    • Simplified treatment protocols enhance care for low-risk differentiated thyroid cancer.
    • Personalized strategies and complication management are key in acromegaly treatment.